Hannah counsels clients in the life science industries to design and execute a global patent strategy. Her work includes drafting patent applications and prosecuting them to issue, as well as managing a prosecution strategy with foreign associates in numerous countries. She also performs freedom-to-operate analysis to help clients understand the extent and strength of third-party positions. In addition, she conducts due diligence on patent portfolios to help venture firms and large pharmaceutical companies gauge the value of their investments. Hannah also has experience working as a member of litigation teams. Throughout her patent law career, she has handled matters in a variety of technology areas, including therapeutic antibodies, peptide therapeutics, antisense therapies, cell-based therapies, diagnostics, and medical devices. Her clients range from Fortune 500 pharmaceutical companies to early stage venture-backed startups.
Before entering patent law, Hannah earned a Ph.D. in cell biology at the University of California, San Francisco. Her thesis work focused on the trafficking of XIST RNA in human tissue culture cells. Hannah is the author of scientific articles in several journals including Science, Chromosoma, and Gene.
Some representative matters include: